Jefferies Group LLC Assembly Biosciences, Inc. Call Options Transaction History

Jefferies Group LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2020 Aug 14, 2020	SELL	$14.57 - $23.96 $1.24 Million - $2.04 Million	-85,000 Closed	0 $0
Q1 2020 Nov 24, 2020	BUY	$10.27 - $21.23 $872,950 - $1.8 Million	85,000 New	85,000 $1.3 Million
Q1 2020 May 15, 2020	SELL	$10.27 - $21.23 $872,950 - $1.8 Million	-85,000 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$8.36 - $23.81 $710,600 - $2.02 Million	85,000 New	85,000 $1.74 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $714M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.